The Rivers State University Teaching Hospital (RSUTH) has taken a major step towards improving paediatric HIV care through a groundbreaking research project conducted in collaboration with Cipher Paediatric HIV Matters.
The study, which focused on optimising the use of paediatric dolutegravir (PDTG) among children living with HIV, has yielded significant results in enhancing treatment outcomes in rural communities.
The findings revealed marked improvements in healthcare workers’ knowledge, confidence, and accuracy in administering the life-saving medication.
Led by Dr. Ihuoma Wali and supported by the Institute of Infectious Disease Research and Development, the project involved intensive training for rural health practitioners on correct PDTG dosing and management.
At a dissemination meeting held on 11th November 2025 in Port Harcourt, stakeholders reviewed the research outcomes and explored strategies for expanding the programme’s reach.
Representing the Honourable Commissioner for Health, Dr. Adaeze Oreh, the Director of Medical Services, Dr. Vincent Nwachukwu, reaffirmed the Ministry’s commitment to supporting such initiatives aimed at reducing the burden of HIV/AIDS among children in the state.
Read Also: Fubara approves free health insurance, others for health workers
The Chief Medical Director of RSUTH, Prof. Chizindu Alikor, applauded the research team for their innovation and dedication, describing the project as “a model for evidence-based healthcare improvement that other institutions should emulate.”
Funded through a grant from the International Paediatric HIV Symposium in Africa (IPHASA), the project reflects the Rivers State Government’s increasing investment in health research and its commitment to achieving equitable access to quality healthcare for all children.
The dissemination meeting brought together health professionals, researchers, and policymakers to discuss ways of scaling up paediatric dolutegravir treatment across Rivers State and beyond.
